Blue toe syndrome.
Casado-Hoces SV, González-Tejedor D, Domínguez-García MA, Reina-Herraiz B.
Rev Esp Sanid Penit. 2023 Sep-Dec;25(3):122-124. doi: 10.18176/resp.00078.
Blue toe syndrome--reply.
Sarici A, Kizilkilic O, Celkan T.
JAMA Ophthalmol. 2014 May;132(5):654-5. doi: 10.1001/jamaophthalmol.2013.8252.
[Blue toe syndrome as an initial manifestation of metastatic prostate cancer : A case report with literature review].
Vignes S, Fourgeaud C, Michon-Pasturel U.
Rev Med Interne. 2022 Sep;43(9):562-565. doi: 10.1016/j.revmed.2022.04.017. Epub 2022 May 25.
Blue Toe Syndrome: A Challenging Diagnosis.
Tartari F, Di Altobrando A, Merli Y, Patrizi A, Mirelli M, Bianchi T.
Indian J Dermatol. 2019 Nov-Dec;64(6):506-507. doi: 10.4103/ijd.IJD_580_18.
Blue toe syndrome.
Sharifkazemi MB, Zamirian M, Aslani A.
J Cardiovasc Med (Hagerstown). 2007 Nov;8(11):975-6. doi: 10.2459/JCM.0b013e328011393e.
Blue toe syndrome.
Hart B.
J Vasc Nurs. 1991 Sep;9(3):2-5.
Blue toe syndrome caused by spontaneous cholesterol embolization syndrome.
Suzuki M, Watari T.
QJM. 2023 Nov 24;116(11):936-937. doi: 10.1093/qjmed/hcad169.
Blue toe syndrome. Causes and management.
O'Keeffe ST, Woods BO, Breslin DJ, Tsapatsaris NP.
Arch Intern Med. 1992 Nov;152(11):2197-202.
The Evolution of Blue Toe Syndrome in a Diabetic Patient.
Deng L, Deng W.
Am J Med. 2023 Jan;136(1):e1-e2. doi: 10.1016/j.amjmed.2022.08.027. Epub 2022 Sep 21.
Blue toe syndrome, severe haemophilia A and emicizumab.
Cardoso PSR, da Silva CBPG, de Abreu ES, Oliveira AG, Pereira IFM, Navarro TP, Rezende SM.
Haemophilia. 2024 Jan;30(1):241-244. doi: 10.1111/hae.14893. Epub 2023 Oct 23.
